DanCann Pharma A/S publishes Q1-2023 report
COPENHAGEN, Denmark, 31 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announce that the Company has published its report for the first quarter of 2023. The Q1-2023 report is available as an attached document to this press release and at www.dancann.com.SUMMARY: GROUP KEY FIGURES Q1 2023 01/01/23 - 31/03/23 01/01/22 - 01/01/22 - 01/10/21 - 31/12/21 31/03/22 31/12/22Net sales